Wednesday, June 19, 2013 5:45:53 PM
Last month’s Sequencing, Finishing, Analysis in the Future (SFAF) meeting in Santa Fe, New Mexico, hosted by Los Alamos National Laboratory, attracted terrific scientists and we really enjoyed hearing about their work as well as sharing our own technology advances. It was great to be at a meeting where genome finishing and analysis were key themes; it was an environment where our customers’ experience with HGAP and Quiver resonated, particularly around the automated finishing of microbial genomes.
SFAF had a number of keynote speakers, including Mark Adams from the J. Craig Venter Institute, who spoke about antibiotic resistance in microbes. He noted that lateral transfer of multidrug resistance genes is creating new drug-resistant pathogens in our hospitals. A key theme in his talk was the need for comprehensive information about the genomes of these drug-resistant microbes, including the difficult-to-assemble regions such as duplications, repetitive sequence, plasmids, and so on. He said that standard strain typing does not provide enough information to distinguish the particular form of resistance between bugs. For example, plasmids and phages play a critical role in horizontal gene transfer of drug resistance genes, yet these elements are notoriously difficult to assemble with short-read NGS methods. Adams commented that PacBio’s HGAP assemblies provide both finished genomes and plasmids, which offer important clues about drug resistance mechanisms and microbial adaptation.
Throughout the conference, many speakers mentioned the challenge of reference-based sequencing when there are errors in the reference, or when the reference is not a good enough representation of the genome being sequenced and compared to it. It was apparent that the trend is shifting back to de novo sequencing, which provides more information about the organism under investigation and is more likely to pick up unexpected differences that are not included in a reference genome. This idea is especially compelling in the microbial world, where pan-genomes and horizontal gene transfer have turned the whole idea of a single reference genome on its head.
Finishing genomes — how to generate them and how much they cost — was another common thread. It was impressive to see how many conference attendees were using the HGAP/Quiver method to finish all sorts of microbial genomes. Ken Dewar from McGill University gave a presentation based on a simple question: Can we sequence one full bacterium in one day for less than $1,000? We were thrilled to see that PacBio’s technology is meeting his goal. In another talk, Adam Phillippy from the National Biodefense Analysis and Countermeasures Center said that with PacBio® technology, it’s now cheaper to finish a microbial genome than it is to publish one. Phillippy noted that once reads exceed 7 kb for microbial genomes, assembly complexity is drastically reduced; using the XL chemistry, 40 percent of their PacBio reads have been at least that long. He and other speakers noted that they have been getting Q60 scores from their PacBio data with the latest hardware and software upgrades.
Most of all, we were inspired by so much compelling science and the community’s renewed commitment to finished genomes. Many attendees talked about their motivation to go back to their labs and try out these new methods for finishing microbial genomes, especially since the whole process can now be automated. http://blog.pacificbiosciences.com/2013/06/back-from-sfaf-and-eager-for-more.html
Recent PACB News
- PacBio and International Research Consortium CoLoRS Announce Release of First-Ever HiFi Long-Read Variant Database • PR Newswire (US) • 06/10/2024 01:05:00 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 05/30/2024 01:52:04 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/22/2024 09:25:43 PM
- Ambry Genetics and PacBio Announce Collaboration to Sequence Up to 7,000 Human Genomes Aimed at Providing Answers for Families Battling Rare Diseases • PR Newswire (US) • 05/15/2024 01:45:00 PM
- Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers • Edgar (US Regulatory) • 05/09/2024 08:33:12 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2024 08:21:46 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 08:12:15 PM
- PacBio Announces First Quarter 2024 Financial Results • PR Newswire (US) • 05/09/2024 08:05:00 PM
- PacBio Announces Preliminary First Quarter 2024 Revenue and Updates 2024 Revenue Guidance • PR Newswire (US) • 04/16/2024 12:05:00 PM
- Estonia National Biobank Selects PacBio to Sequence 10,000 Whole Genomes • PR Newswire (US) • 03/27/2024 12:00:00 PM
- PacBio Grants Equity Incentive Award to New Employee • PR Newswire (US) • 03/22/2024 08:30:00 PM
- PacBio Announces PureTarget™ Repeat Expansion Panel, Expanding its Portfolio of End-to-End Clinical Research Solutions • PR Newswire (US) • 03/12/2024 01:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 10:36:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 10:30:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 10:26:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 10:22:45 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/04/2024 11:32:39 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/04/2024 11:22:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2024 09:55:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2024 09:36:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2024 09:25:48 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2024 09:19:42 PM
- PacBio to Present at Upcoming Investor Conferences • PR Newswire (US) • 02/26/2024 09:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/21/2024 11:25:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/21/2024 11:20:57 PM
FEATURED Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • Jun 14, 2024 2:07 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM
Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM
Element79 Gold Corp Files for OTCQB Uplisting, Provides Financial Update • ELEM • Jun 11, 2024 9:25 AM